Researchers may have solved the world's drug-resistant bacteria problem using artificial intelligence

Petri dish
(Image credit: William West/AFP/Getty Images)

Researchers at MIT reported Thursday that they have harnessed artificial intelligence to identify a completely new antibiotic compound that killed all but one of the antibacterial-resistant pathogens they tested it on. Drug-resistant bacteria are a large and growing problem, causing 2.8 million infections and 35,000 deaths in the U.S. each year and more in developing countries, STAT News reports. The computer learning model developed at MIT, described in the journal Cell, has the potential to identify many new types of antibiotics.

The researchers named the compound halicin, after HAL, the initially useful, eventually murderous sentient computer in 2001: A Space Odyssey. They also discovered eight more promising antibacterial compounds, two of which appear very powerful. They tried out halicin on mice and plan to work with a nonprofit or drugmaker to see if it's effective and safe in humans.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Peter Weber, The Week US

Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.